Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1975-5-5
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0090-4295
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
131-2
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1114534-Administration, Oral,
pubmed-meshheading:1114534-Animals,
pubmed-meshheading:1114534-Drug Evaluation,
pubmed-meshheading:1114534-Molecular Conformation,
pubmed-meshheading:1114534-Mycophenolic Acid,
pubmed-meshheading:1114534-Neoplasms, Experimental,
pubmed-meshheading:1114534-Time Factors,
pubmed-meshheading:1114534-Urinary Bladder Neoplasms
|
pubmed:year |
1975
|
pubmed:articleTitle |
Use of mycophenolic acid in superifical bladder cancer.
|
pubmed:publicationType |
Journal Article
|